Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Mpox poses an ever-increasing epidemic and pandemic risk

An Author Correction to this article was published on 16 April 2025

This article has been updated

The human interaction with mpox has changed across its entire endemic range, revealing the endemic and pandemic risk of monkeypox virus and the current knowledge gaps on its biology that hamper virus control.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Transmission and dissemination of MPXV in animals and humans.
Fig. 2: Emergence of MPXV clades in Sub-Saharan Africa since 2022.

Change history

References

  1. Fenner, F., Henderson, D. A., Arita, I., Zdenek, J. & Ladnyi, I. D. Smallpox and its Eradication (WHO, 1988).

  2. MacNeill, A. L. Pathogens 11, 892 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ježek, Z., Grab, B., Szczeniowski, M., Paluku, K. & Mutombo, M. Bull. World Health Organ. 66, 459 (1988).

    PubMed  PubMed Central  Google Scholar 

  4. Ježek, Z., Grab, B., Szczeniowski, M., Paluku, K. & Mutombo, M. Bull. World Health Organ. 66, 465 (1988).

    PubMed  PubMed Central  Google Scholar 

  5. Ndodo, N. et al. Nat. Med. 29, 2317–2324 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ulaeto, D. O., Dunning, J. & Carroll, M. W. Lancet Microbe 3, e639–e640 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  7. World Health Organization. Multi-country outbreak of mpox, external situation report #42 (9 November 2024).

  8. Wawina-Bokalanga, T. et al. Euro. Surveill. 29, 2400592 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  9. O’Toole, Á. et al. Science 382, 595–600 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Aguado, B., Selmes, I. P. & Smith, G. L. J. Gen. Virol. 73, 2887–2902 (1992).

    Article  CAS  PubMed  Google Scholar 

  11. Vakaniaki, E. H. et al. Nat. Med. 30, 2791–2795 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wannigama, D. L. et al. Lancet Infect. Dis. 24, e348–e350 (2024).

    Article  PubMed  Google Scholar 

  13. Likos, A. M. et al. J. Gen. Virol. 86, 2661–2672 (2005).

    Article  CAS  PubMed  Google Scholar 

  14. Smith, T. G. et al. Emerg. Infect. Dis. 29, 2426 (2023).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Garrigues, J. M. et al. Antimicrob. Agents Chemother. 67, e00972–00923 (2023).

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Carlos Maluquer de Motes or David O. Ulaeto.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maluquer de Motes, C., Ulaeto, D.O. Mpox poses an ever-increasing epidemic and pandemic risk. Nat Med 31, 1743–1746 (2025). https://doi.org/10.1038/s41591-025-03589-8

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41591-025-03589-8

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing